Your browser doesn't support javascript.
loading
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature.
Grillo, Piergiorgio; DI Giuliano, Francesca; Massa, Roberto; Mercuri, Nicola Biagio; Schirinzi, Tommaso.
Afiliación
  • Grillo P; Neurology Unit, Department of Systems Medicine, University of Roma Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  • DI Giuliano F; Neuroradiology Unit, Department of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.
  • Massa R; Neurology Unit, Department of Systems Medicine, University of Roma Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  • Mercuri NB; Neurology Unit, Department of Systems Medicine, University of Roma Tor Vergata, via Montpellier 1, 00133, Rome, Italy.
  • Schirinzi T; IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano, Rome, Italy.
Neurol Sci ; 42(3): 905-910, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33443666
BACKGROUND: Recognition of secondary movement disorders (SMDs) is fundamental either to alleviate disabling disturbances or to treat potentially life-threatening conditions, such as brain tumors. Primary CNS lymphoma (PCNSL) is a rare form of CNS cancer that is often located in subcortical areas, accounting for both neuropsychiatric and motoric disorders. Nevertheless, an overview on PCNSL-related movement disorders (MDs) phenomenology has not been provided yet. OBJECTIVE: To outline the main features of PCNSL-related MDs. METHODS: A retrospective analysis was conducted on a cohort of patients with PCNSL presenting with MDs, including all existing cases identified by a systematic literature review (source: Medline; period: 1946-2020) and two unreported cases. Data on phenomenology, neuroimaging, histology, and clinical course were collected. RESULTS: A total cohort of fifteen subjects was defined, enrolling thirteen previously described patients extracted from eleven published studies, and our two unreported cases. A parkinsonian syndrome appearing at about 60 years of age, unresponsive to levodopa, associated to other neurological signs, resulted as the most common presentation of PCNSL-related MD. Chorea, dystonia, and dyskinesia occurred less frequently, with some degree of responsiveness to symptomatic treatments. Basal ganglia were involved in most cases and motoric disturbances often ameliorated after tumor mass reduction. CONCLUSIONS: This study identified those features of PCNSL-related MDs that could support an appropriate approach to such a rare condition. In fact, while the outcome remains still poor, the therapeutic scenario of PCNSL is changing; an early diagnosis together with an adequate management will be thus crucial for timely and successful interventions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central / Trastornos del Movimiento Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias Encefálicas / Neoplasias del Sistema Nervioso Central / Trastornos del Movimiento Tipo de estudio: Etiology_studies / Observational_studies / Qualitative_research / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia